It has been proposed that Cbl-b functions as an E3 ubiquitin protein ligase, thereby negatively regulating receptor tyrosine kinase (RTK) signal-transduction pathways and inhibiting tumor growth (7, 8). The gene discussed is UBE2E3; the disease is neoplasm.